Avinger (AVGR)
(Delayed Data from NSDQ)
$0.78 USD
0.00 (0.00%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $0.79 +0.01 (1.28%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.78 USD
0.00 (0.00%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $0.79 +0.01 (1.28%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Zacks News
SurModics (SRDX) Beats Earnings & Revenue Estimates in Q1
by Zacks Equity Research
Surmodics, Inc. (SRDX) reported earnings of 19 cents per share in the first-quarter of fiscal 2017 surpassing the Zacks Consensus Estimate of 9 cents.
Pacific Biosciences (PACB) Q4 Loss Narrower than Estimated
by Zacks Equity Research
Pacific Biosciences of California Inc. (PACB), a pioneer in the field of single molecule long resequencing, reported loss of 21 cents per share in the fourth quarter of 2016, 2 cents narrower than the Zacks Consensus Estimate.
athenahealth (ATHN) Beats on Q4 Earnings, Misses Revenues
by Zacks Equity Research
athenahealth (ATHN) reported adjusted earnings of 42 cents per share, which beat the Zacks Consensus Estimate of 27 cents.
PerkinElmer (PKI) Misses Q4 Earnings & Revenue Estimates
by Zacks Equity Research
Waltham, MA-based PerkinElmer Inc (PKI) reported fourth-quarter 2016 earnings of 83 cents per share missing the Zacks Consensus Estimate of 86 cents
CONMED (CNMD) Q4 Earnings Miss Estimates, Increase Y/Y
by Zacks Equity Research
Headquartered in Utica, NY, leading medical technology player, CONMED Corporation (CNMD) reported fourth-quarter 2016 adjusted earnings of 54 cents per share, missing the Zacks Consensus Estimate by 2 cents.
Baxter International (BAX) Q4 Earnings Beat, Revenues Lag
by Zacks Equity Research
Baxter International Inc. (BAX) reported fourth-quarter 2016 adjusted earnings of 57 cents per share, which surpassed the Zacks Consensus Estimate by 5 cents and were well above the year-ago figure of 43 cents.
Zacks.com featured highlights: Calavo Growers, Avinger, Bridgeline Digital, NextEra Energy Partners and Universal Health Services
by Zacks Equity Research
Zacks.com featured highlights: Calavo Growers, Avinger, Bridgeline Digital, NextEra Energy Partners and Universal Health Services
Profit from These 5 Stocks with Rising P/E Ratio
by Zacks Equity Research
Forget undervalued stocks, there is room for upside even in stocks with rising P/E.
Buy 5 Stocks with Rising P/E to Bust a Common Myth
by Zacks Equity Research
Forget undervalued stocks, buy these top-ranked stocks with rising P/E.